Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Yuanjun ChengYongbing ChenGuohui ZangBin ChenJie YaoWenguang ZhangHaibing WangLiu YuPinghai HeYouming ZhangHanqing WuPublished in: Cancer management and research (2020)
In the malignant progression of NSCLC, our results demonstrate how the promoting role of the upregulated TAP expression takes place. Hence, a therapeutic aim for NSCLC and a potential biomarker for NSCLC progress is a TAP.